BioLife Solutions, Inc.

8-K Regulation FD disclosure Aug 3, 2026 8-K Entered a material agreement; Regulation FD disclosure Jul 22, 2026 8-K Regulation FD disclosure Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 28, 2026 8-K Regulation FD disclosure Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Director or officer change Jan 9, 2026 8-K Regulation FD disclosure Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Shareholder vote results Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 8, 2025 8-K Director or officer change Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Mar 3, 2025 8-K Jan 13, 2025 8-K Director or officer change Dec 20, 2024 8-K Entered a material agreement; Completed an acquisition or disposition Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Amended charter or bylaws Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K/A Results of operations (earnings release) Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Aug 6, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement; Completed an acquisition or disposition Apr 23, 2024 8-K Exit or disposal costs; Other events Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Feb 29, 2024 8-K Results of operations (earnings release) Jan 8, 2024